We recently published a list of Did Jim Cramer Hit or Miss On These 13 Stock Predictions? In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other stocks that Jim Cramer discussed during the episode of Mad Money on May 1st, 2024.
During the Mad Money episode which aired on Tuesday, Jim Cramer discussed how stock ownership is viewed in the United States, saying:
“Alright, look, lately, we can’t go a day without hearing some widespread misperceptions about stock ownership. I gotta tell you, I think it’s infuriating. Here we are celebrating the 20th anniversary of Mad Money, dedicated to the proposition that you can potentially make lots of money by picking individual stocks, yet I keep hearing that most Americans don’t care about the stock market, and this direction means nothing.”
READ ALSO: How Did Jim Cramer’s 12 Bold Predictions Play Out? and Did Jim Cramer Nail All These 9 Stock Predictions?
Jim Cramer challenged the idea that the stock market only serves the wealthy, calling it a flawed and dismissive perspective that overlooks the financial involvement of millions of ordinary Americans, saying:
“It’s the whole reason anyone watches the darn show, and it generally matters, not just to the rich, but to tens of millions of regular people, home gamers, and never let any politician tell you otherwise. […] More than 60% of Americans have some exposure to the market, either directly or indirectly. 70 million people have active 401Ks. Millions more have retired with them. 60 million people have IRAs. Only 156 million people voted in November. I mean, we’re talking half the electorate here.”
Cramer argued that stockholders make up a major segment of the population and should not be ignored. He stated, “It’s not just arrogant, rich people who own stocks.” He also criticized affluent individuals who caution others against investing in stocks while continuing to benefit from their tax advantages. As he put it:
“Now look, stocks are ridiculously tax advantaged, more than just rich people want that. In a world where probably no more than 10% of this country can retire on their paycheck savings, stocks represent a different kind of social security, a one-sided pack where people try to save and the government dismisses them.”
Methodology
For this article, we compiled a list of 13 stocks that were discussed by Jim Cramer during the episode of Mad Money on May 1st, 2024. We then calculated their performance from May 1st, 2024, market close to April 30th, 2025, market close. We have also included the hedge fund sentiment for the stocks, which we sourced from Insider Monkey’s Q4 2024 database of over 900 hedge funds. The stocks are listed in the order that Cramer mentioned them.
Please note that this article mentions Jim Cramer’s previous opinions and may not account for any changes to his opinions regarding the stocks that are mentioned. It is primarily an examination of how his previously provided opinions have panned out.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
Bristol-Myers Squibb Company (NYSE:BMY)
Number of Hedge Fund Investors: 70
When a caller asked about Bristol-Myers Squibb Company (NYSE:BMY), Cramer responded negatively, citing weak pipeline prospects discussed at an earlier J.P. Morgan healthcare conference. Here’s what Jim Cramer said at the time:
“They told you when we were at J.P. Morgan that look, we don’t have the horses now, but the dividend is safe. I mean, what that was, was the crowd Clarion call to move out. At these prices I I still think the clarion call is on—feels a little like ‘fear me’.”
Cramer’s call was a miss, as the stock has risen by 13.28% since those comments.
However, he is increasingly more bullish on Bristol-Myers Squibb Company (NYSE:BMY) in recent episodes. Here’s what he said a few days ago:
“I’m going to say something that could get me in trouble, but I, I like the market at this level. I really do. But I’ve got to tell you, and Michael, you know I play it straight, I like Bristol Myers a lot more—BMY. I like it a lot more because the schizophrenia drug is on the come.”
Overall, BMY ranks 6th on our list of stocks that Jim Cramer discussed during the episode of Mad Money on May 1st, 2024. While we acknowledge the potential of BMY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than BMY but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
